⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6866082 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL12626878 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL12660610 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL17574280 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL14407687 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL1662191 | 0.94 | — | — | |
| SCHEMBL811021 | 0.87 | — | — | |
| SCHEMBL1837402 | 0.79 | FFAR3 (0.48) | — | |
| SCHEMBL13954105 | 0.79 | FFAR3 (0.48) | — | |
| SCHEMBL16892256 | 0.78 | FFAR3 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024030651-A1 | GPX4 INHIBITORS AND USE THEREOF | SONATA THERAPEUTICS, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| EP-4309741-A1 | CYCLIC COMPOUND HAVING INHIBITORY EFFECT SELECTIVE FOR KRAS BUT NOT FOR HRAS AND NRAS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20230144324-A1 | PCSK9 ANTAGONIST COMPOUNDS | MERCK SHARP & DOHME LLC | 2023-05-11 | — | — | US | disclosed |
| US-20210163536-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA SAS (FR) | 2021-06-03 | — | — | US | disclosed |
| US-20190111105-A1 | Use of Melanocortins to Treat Insulin Sensitivity | IPSEN PHARMA S.A.S. (FR) | 2019-04-18 | — | — | US | disclosed |
| EP-3019196-B1 | COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-06-06 | — | — | EP | disclosed |
| US-20180118784-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA S.A.S. (FR) | 2018-05-03 | — | — | US | disclosed |
| EP-2802326-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-04-18 | — | — | EP | disclosed |
| US-9845339-B2 | Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers | RHYTHM PHARMACEUTICALS, INC. (US) | 2017-12-19 | — | — | US | disclosed |
| US-9827286-B2 | Use of melanocortins to treat insulin sensitivity | IPSEN PHARMA S.A.S. (FR) | 2017-11-28 | — | — | US | disclosed |
| US-20110319422-A1 | PRODRUGS OF NH-ACIDIC COMPOUNDS: ESTER, CARBONATE, CARBAMATE AND PHOSPHONATE DERIVATIVES | ALKERMES, INC. (US) | 2011-12-29 | — | — | US | disclosed |
| WO-2011017209-A1 | USE OF MELANOCORTINS TO TREAT DYSLIPIDEMIA | IPSEN PHARMA S.A.S. (FR) | 2011-02-10 | — | — | WO | disclosed |
| US-20100317848-A1 | PROCESS FOR THE SYNTHESIS OF DERIVATIVES OF 3-AMINO-TETRAHYDROFURAN-3-CARBOXYLIC ACID AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-12-16 | — | — | US | disclosed |
| US-20100311647-A1 | USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY | IPSEN PHARMA S.A.S. (FR) | 2010-12-09 | — | — | US | disclosed |
| US-20100184646-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA S.A.S. (FR) | 2010-07-22 | — | — | US | disclosed |
| WO-2009061411-A2 | USE MELANOCORTINS TO TREAT INSULIN SENSITIVITY | IPSEN PHARMA S.A.S. (FR) | 2009-05-14 | — | — | WO | disclosed |
| WO-2008147556-A2 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA S.A.S. (FR) | 2008-12-04 | — | — | WO | disclosed |
| EP-1043298-A1 | PROCESSES FOR THE PREPARATION OF ALCOHOLS | Daicel Chemical Industries, Ltd. (JP) | 2000-10-11 | — | — | EP | disclosed |
| EP-0021525-B1 | PROCESS FOR THE PREPARATION OF CARBOXYLATED COMPOUNDS | INTEROX Société Anonyme (BE) | 1984-02-29 | — | — | EP | disclosed |
| US-4353832-A | OXIDATION OF CARBONYL COMPOUND TO CARBOXYL COMPOUND IN PRESENCE OF CATALYST AND ABSENCE OF WATER | INTEROX (SOCIETE ANONYME) (BE) | 1982-10-12 | — | — | US | disclosed |